In
chronic kidney disease, elevated levels of circulating
uremic toxins are associated with a variety of symptoms and organ dysfunction.
Indoxyl sulfate (IS) and p-cresyl
sulfate (pCS) are microbiota-derived metabolites and representative
uremic toxins. We have previously shown that the oral adsorbent
AST-120 profoundly reduced pCS compared to IS in
adenine-induced
renal failure in mice. However, the mechanisms of the different attenuation effects of
AST-120 between IS and pCS are unclear. To clarify the difference of
AST-120 on IS and pCS, we investigated the levels of fecal
indole and
p-cresol, the respective precursors of IS and pCS, and examined the influence on the gut microbiota. Although fecal
indole was detected in all groups analyzed, fecal
p-cresol was not detected in
AST-120 treatment groups. In genus level, a total of 23 organisms were significantly changed by
renal failure or
AST-120 treatment. Especially,
AST-120 reduced the abundance of Erysipelotrichaceae uncultured and Clostridium sensu stricto 1, which have a gene involved in
p-cresol production. Our findings suggest that, in addition to the adsorption of the uremic toxin precursors,
AST-120 affects the abundance of some gut microbiota in normal and
renal failure conditions, thereby explaining the different attenuation effects on IS and pCS.